News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytel Inc.-Designed Adaptive Confirmatory Study Poster Accepted at American Society of Clinical Oncology 2011


5/23/2011 8:49:08 AM

Cytel Inc., the premier provider of adaptive clinical trial services and biostatistical software, today announced that a jointly authored review of Sunesis Pharmaceuticals’ VALOR trial adaptive design will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES